| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.838 | 0.003 | 0.848 | 5 Hydroxytryptamine release stimulant | 0.848 0.003 CID_159959 | CID_159959 | |
| 0.631 | 0.032 | 0.631 | Caspase 9 stimulant | 0.575 0.04 CID_159959 | ||
| 0.602 | 0.004 | 0.602 | 5 Hydroxytryptamine agonist | 0.538 0.004 CID_159959 | ||
| 0.541 | 0.004 | 0.541 | 5 Hydroxytryptamine 2C antagonist | 0.327 0.008 CID_159959 | ||
| 0.539 | 0.004 | 0.784 | Tyrosine 3 hydroxylase inhibitor | 0.784 0.002 CID_159959 | CID_159959 | |
| 0.541 | 0.008 | 0.559 | Psychostimulant | 0.559 0.007 CID_159959 | CID_159959 | |
| 0.541 | 0.01 | 0.594 | Superoxide dismutase inhibitor | 0.594 0.007 CID_159959 | CID_159959 | |
| 0.522 | 0.005 | 0.522 | 5 Hydroxytryptamine 2B antagonist | 0.377 0.01 CID_159959 | ||
| 0.518 | 0.004 | 0.518 | Alpha 2a adrenoreceptor antagonist | 0.46 0.004 CID_159959 | ||
| 0.512 | 0.007 | 0.512 | 5 Hydroxytryptamine antagonist | 0.296 0.019 CID_159959 | ||
| 0.504 | 0.006 | 0.504 | 5 Hydroxytryptamine 2 antagonist | 0.342 0.013 CID_159959 | ||
| 0.462 | 0.004 | 0.462 | Alpha 2 adrenoreceptor antagonist | 0.363 0.005 CID_159959 | ||
| 0.446 | 0.004 | 0.446 | Alpha 2b adrenoreceptor antagonist | 0.356 0.006 CID_159959 | ||
| 0.475 | 0.038 | 0.529 | Calcium channel L-type activator | 0.529 0.018 CID_159959 | CID_159959 | |
| 0.442 | 0.008 | 0.442 | Alpha adrenoreceptor antagonist | 0.286 0.017 CID_159959 | ||
| 0.464 | 0.036 | 0.464 | Vasodilator, peripheral | 0.455 0.039 CID_159959 | ||
| 0.43 | 0.006 | 0.43 | 5 Hydroxytryptamine 2A antagonist | 0.265 0.014 CID_159959 | ||
| 0.451 | 0.041 | 0.596 | GABA C receptor rho-3 antagonist | 0.596 0.008 CID_159959 | CID_159959 | |
| 0.409 | 0.003 | 0.409 | 5 Hydroxytryptamine 5A antagonist | 0.276 0.004 CID_159959 | ||
| 0.406 | 0.003 | 0.406 | 5 Hydroxytryptamine 5 antagonist | 0.251 0.004 CID_159959 | ||
| 0.397 | 0.004 | 0.446 | GABA C receptor rho-2 antagonist | 0.446 0.003 CID_159959 | CID_159959 | |
| 0.392 | 0.005 | 0.392 | 5 Hydroxytryptamine 1 agonist | 0.319 0.006 CID_159959 | ||
| 0.386 | 0.003 | 0.558 | GABA C receptor antagonist | 0.558 0.002 CID_159959 | CID_159959 | |
| 0.399 | 0.025 | 0.466 | Amyloid beta aggregation inhibitor | 0.466 0.017 CID_159959 | CID_159959 | |
| 0.393 | 0.027 | 0.393 | Calcium channel activator | 0.342 0.055 CID_159959 | ||
| 0.352 | 0.006 | 0.352 | Toll-Like receptor 9 antagonist | 0.276 0.016 CID_159959 | ||
| 0.345 | 0.005 | 0.345 | Alpha 2c adrenoreceptor antagonist | 0.264 0.009 CID_159959 | ||
| 0.361 | 0.023 | 0.361 | Cyclic AMP phosphodiesterase inhibitor | 0.361 0.023 CID_159959 | ||
| 0.341 | 0.004 | 0.347 | MAP-kinase-activated kinase inhibitor | 0.347 0.004 CID_159959 | CID_159959 | |
| 0.335 | 0.005 | 0.335 | 5 Hydroxytryptamine 1A agonist | 0.249 0.007 CID_159959 | ||
| 0.415 | 0.088 | 0.415 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.41 0.092 CID_159959 | ||
| 0.326 | 0.003 | 0.326 | 5 Hydroxytryptamine 2C agonist | 0.312 0.004 CID_159959 | ||
| 0.355 | 0.034 | 0.366 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.366 0.03 CID_159959 | CID_159959 | |
| 0.313 | 0.003 | 0.313 | 5 Hydroxytryptamine 2 agonist | 0.212 0.004 CID_159959 | ||
| 0.362 | 0.053 | 0.567 | Aldehyde oxidase inhibitor | 0.567 0.023 CID_159959 | CID_159959 | |
| 0.311 | 0.004 | 0.316 | MAP-kinase-activated kinase 2 inhibitor | 0.316 0.003 CID_159959 | CID_159959 | |
| 0.307 | 0.003 | 0.39 | GABA C receptor rho-1 antagonist | 0.39 0.002 CID_159959 | CID_159959 | |
| 0.328 | 0.033 | 0.357 | 5 Hydroxytryptamine uptake stimulant | 0.357 0.023 CID_159959 | CID_159959 | |
| 0.302 | 0.013 | 0.302 | Antiadrenergic | 0.265 0.016 CID_159959 | ||
| 0.308 | 0.025 | 0.308 | 5 Hydroxytryptamine 1E antagonist | 0.295 0.033 CID_159959 | ||
| 0.321 | 0.046 | 0.376 | Hypoglycemic | 0.376 0.032 CID_159959 | CID_159959 | |
| 0.287 | 0.014 | 0.287 | Adrenaline antagonist | 0.249 0.017 CID_159959 | ||
| 0.357 | 0.095 | 0.438 | 15-Lipoxygenase inhibitor | 0.438 0.059 CID_159959 | CID_159959 | |
| 0.283 | 0.027 | 0.338 | Thrombolytic | 0.338 0.018 CID_159959 | CID_159959 | |
| 0.28 | 0.036 | 0.289 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.289 0.031 CID_159959 | CID_159959 | |
| 0.295 | 0.053 | 0.307 | Antiamyloidogenic | 0.307 0.049 CID_159959 | CID_159959 | |
| 0.25 | 0.008 | 0.25 | 5 Hydroxytryptamine 7 antagonist | 0.187 0.014 CID_159959 | ||
| 0.245 | 0.005 | 0.251 | MAP3K9 inhibitor | 0.251 0.005 CID_159959 | CID_159959 | |
| 0.253 | 0.014 | 0.253 | Toll-Like receptor antagonist | 0.242 0.017 CID_159959 | ||
| 0.293 | 0.06 | 0.299 | DNA damaging | 0.299 0.057 CID_159959 | CID_159959 | |
| 0.253 | 0.02 | 0.276 | NADPH oxidase inhibitor | 0.276 0.016 CID_159959 | CID_159959 | |
| 0.246 | 0.014 | 0.289 | Death-associated protein kinase 2 inhibitor | 0.289 0.008 CID_159959 | CID_159959 | |
| 0.245 | 0.015 | 0.245 | Dopamine antagonist | 0.196 0.019 CID_159959 | ||
| 0.229 | 0.004 | 0.229 | 5 Hydroxytryptamine 2A agonist | 0.176 0.004 CID_159959 | ||
| 0.28 | 0.057 | 0.406 | Free radical scavenger | 0.406 0.028 CID_159959 | CID_159959 | |
| 0.236 | 0.014 | 0.236 | 5 Hydroxytryptamine 1 antagonist | 0.109 0.034 CID_159959 | ||
| 0.236 | 0.014 | 0.236 | Dopamine D2 antagonist | 0.186 0.018 CID_159959 | ||
| 0.266 | 0.045 | 0.266 | Platelet aggregation inhibitor | 0.157 0.12 CID_159959 | ||
| 0.242 | 0.022 | 0.258 | MAO A inhibitor | 0.258 0.02 CID_159959 | CID_159959 | |
| 0.228 | 0.009 | 0.328 | Dopamine D1 antagonist | 0.328 0.005 CID_159959 | CID_159959 | |
| 0.226 | 0.01 | 0.266 | Protein kinase C gamma inhibitor | 0.266 0.005 CID_159959 | CID_159959 | |
| 0.22 | 0.005 | 0.22 | 5 Hydroxytryptamine 1D antagonist | 0.126 0.015 CID_159959 | ||
| 0.301 | 0.094 | 0.38 | Transcription factor NF kappa B inhibitor | 0.38 0.068 CID_159959 | CID_159959 | |
| 0.221 | 0.018 | 0.221 | Alpha 1 adrenoreceptor antagonist | 0.113 0.039 CID_159959 | ||
| 0.209 | 0.009 | 0.246 | TRPA1 agonist | 0.246 0.005 CID_159959 | CID_159959 | |
| 0.228 | 0.029 | 0.228 | 5 Hydroxytryptamine 3E antagonist | 0.218 0.039 CID_159959 | ||
| 0.202 | 0.004 | 0.202 | 5 Hydroxytryptamine 7 agonist | 0.116 0.005 CID_159959 | ||
| 0.259 | 0.063 | 0.259 | HERG channel blocker | 0.157 0.123 CID_159959 | ||
| 0.261 | 0.07 | 0.261 | Tumour necrosis factor alpha release inhibitor | 0.188 0.12 CID_159959 | ||
| 0.219 | 0.032 | 0.219 | Tubulin antagonist | 0.118 0.082 CID_159959 | ||
| 0.201 | 0.014 | 0.201 | 5 Hydroxytryptamine 1A antagonist | 0.095 0.034 CID_159959 | ||
| 0.245 | 0.061 | 0.245 | Antimitotic | |||
| 0.188 | 0.005 | 0.188 | Phosphodiesterase 11A inhibitor | 0.148 0.011 CID_159959 | ||
| 0.188 | 0.005 | 0.188 | Phosphodiesterase XI inhibitor | 0.148 0.011 CID_159959 | ||
| 0.229 | 0.049 | 0.229 | Focal adhesion kinase 2 inhibitor | 0.153 0.126 CID_159959 | ||
| 0.195 | 0.015 | 0.216 | Antineoplastic alkaloid | 0.216 0.01 CID_159959 | CID_159959 | |
| 0.183 | 0.007 | 0.197 | GABA receptor antagonist | 0.197 0.006 CID_159959 | CID_159959 | |
| 0.179 | 0.009 | 0.208 | Cyclin B3 inhibitor | 0.208 0.005 CID_159959 | CID_159959 | |
| 0.204 | 0.035 | 0.204 | Activin receptor-like kinase 2 inhibitor | 0.16 0.059 CID_159959 | ||
| 0.241 | 0.072 | 0.241 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.316 | 0.147 | 0.348 | 5 Hydroxytryptamine release inhibitor | 0.348 0.117 CID_159959 | CID_159959 | |
| 0.185 | 0.016 | 0.185 | Alpha 1b adrenoreceptor antagonist | 0.117 0.03 CID_159959 | ||
| 0.186 | 0.018 | 0.186 | Alpha 1a adrenoreceptor antagonist | 0.095 0.038 CID_159959 | ||
| 0.213 | 0.046 | 0.213 | Tumour necrosis factor antagonist | |||
| 0.236 | 0.078 | 0.258 | Vasodilator | 0.258 0.065 CID_159959 | CID_159959 | |
| 0.165 | 0.007 | 0.169 | GABA A receptor antagonist | 0.169 0.007 CID_159959 | CID_159959 | |
| 0.173 | 0.015 | 0.268 | Protein kinase C zeta inhibitor | 0.268 0.006 CID_159959 | CID_159959 | |
| 0.27 | 0.115 | 0.27 | Vasodilator, coronary | 0.236 0.148 CID_159959 | ||
| 0.167 | 0.019 | 0.167 | Breast cancer-resistant protein inhibitor | 0.122 0.038 CID_159959 | ||
| 0.229 | 0.082 | 0.266 | Platelet antagonist | 0.266 0.066 CID_159959 | CID_159959 | |
| 0.174 | 0.027 | 0.174 | Butyrylcholinesterase inhibitor | 0.125 0.044 CID_159959 | ||
| 0.186 | 0.039 | 0.201 | Cyclin-dependent kinase 7 inhibitor | 0.201 0.033 CID_159959 | CID_159959 | |
| 0.156 | 0.01 | 0.199 | Vanilloid agonist | 0.199 0.007 CID_159959 | CID_159959 | |
| 0.149 | 0.005 | 0.176 | Poly(ADP-ribose) polymerase inhibitor | 0.176 0.005 CID_159959 | CID_159959 | |
| 0.147 | 0.005 | 0.168 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.168 0.005 CID_159959 | CID_159959 | |
| 0.143 | 0.002 | 0.143 | Imidazoline I1 receptor antagonist | 0.076 0.003 CID_159959 | ||
| 0.147 | 0.006 | 0.147 | 5 Hydroxytryptamine 6 antagonist | 0.097 0.016 CID_159959 | ||
| 0.146 | 0.006 | 0.146 | Toll-Like receptor 7 antagonist | 0.112 0.014 CID_159959 | ||
| 0.155 | 0.016 | 0.155 | MAP kinase 11 inhibitor | 0.148 0.018 CID_159959 | ||
| 0.205 | 0.071 | 0.282 | Neurotrophic factor enhancer | 0.282 0.024 CID_159959 | CID_159959 | |
| 0.147 | 0.013 | 0.147 | 5 Hydroxytryptamine 1B antagonist | 0.09 0.028 CID_159959 | ||
| 0.182 | 0.049 | 0.212 | Catenin beta inhibitor | 0.212 0.024 CID_159959 | CID_159959 | |
| 0.202 | 0.07 | 0.223 | Platelet adhesion inhibitor | 0.223 0.06 CID_159959 | CID_159959 | |
| 0.186 | 0.053 | 0.186 | Cholinergic | 0.133 0.093 CID_159959 | ||
| 0.151 | 0.019 | 0.222 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.222 0.011 CID_159959 | CID_159959 | |
| 0.155 | 0.024 | 0.17 | Protein kinase C mu inhibitor | 0.17 0.018 CID_159959 | CID_159959 | |
| 0.175 | 0.044 | 0.175 | Phosphodiesterase inhibitor | |||
| 0.166 | 0.037 | 0.204 | MAP kinase kinase 4 inhibitor | 0.204 0.012 CID_159959 | CID_159959 | |
| 0.199 | 0.072 | 0.199 | I kappa B kinase epsilon inhibitor | 0.163 0.106 CID_159959 | ||
| 0.143 | 0.016 | 0.207 | Check point kinase 1 inhibitor | 0.207 0.009 CID_159959 | CID_159959 | |
| 0.162 | 0.035 | 0.173 | MAP kinase 12 inhibitor | 0.173 0.031 CID_159959 | CID_159959 | |
| 0.205 | 0.08 | 0.223 | Nitric-oxide synthase stimulant | 0.223 0.056 CID_159959 | CID_159959 | |
| 0.155 | 0.034 | 0.157 | Vanilloid 1 agonist | 0.157 0.032 CID_159959 | CID_159959 | |
| 0.196 | 0.079 | 0.227 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.227 0.06 CID_159959 | CID_159959 | |
| 0.149 | 0.034 | 0.326 | GABA C receptor agonist | 0.326 0.008 CID_159959 | CID_159959 | |
| 0.161 | 0.046 | 0.202 | Adenylate cyclase stimulant | 0.202 0.013 CID_159959 | CID_159959 | |
| 0.166 | 0.053 | 0.166 | MAO inhibitor | 0.166 0.053 CID_159959 | ||
| 0.115 | 0.005 | 0.124 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.124 0.005 CID_159959 | CID_159959 | |
| 0.15 | 0.04 | 0.15 | Death-associated protein kinase 1 inhibitor | 0.139 0.059 CID_159959 | ||
| 0.114 | 0.005 | 0.114 | Nicotinic alpha3beta2 receptor antagonist | 0.112 0.005 CID_159959 | ||
| 0.111 | 0.004 | 0.111 | Ryanodine receptor antagonist | 0.083 0.008 CID_159959 | ||
| 0.125 | 0.018 | 0.125 | Alpha 1d adrenoreceptor antagonist | 0.064 0.038 CID_159959 | ||
| 0.27 | 0.166 | 0.27 | MAP kinase kinase 6 inhibitor | 0.263 0.174 CID_159959 | ||
| 0.138 | 0.036 | 0.147 | Check point kinase 2 inhibitor | 0.147 0.032 CID_159959 | CID_159959 | |
| 0.12 | 0.019 | 0.12 | Phosphodiesterase V inhibitor | 0.101 0.027 CID_159959 | ||
| 0.202 | 0.101 | 0.273 | MAP-kinase-activated kinase 5 inhibitor | 0.273 0.045 CID_159959 | CID_159959 | |
| 0.141 | 0.04 | 0.178 | 5 Hydroxytryptamine 3A agonist | 0.178 0.022 CID_159959 | CID_159959 | |
| 0.144 | 0.044 | 0.205 | Topoisomerase I inhibitor | 0.205 0.025 CID_159959 | CID_159959 | |
| 0.152 | 0.054 | 0.152 | Acetylcholinesterase inhibitor | 0.109 0.09 CID_159959 | ||
| 0.129 | 0.032 | 0.203 | Prolactin inhibitor | 0.203 0.008 CID_159959 | CID_159959 | |
| 0.116 | 0.02 | 0.116 | Phosphodiesterase 5A inhibitor | 0.094 0.029 CID_159959 | ||
| 0.105 | 0.009 | 0.144 | MAP kinase kinase 7 inhibitor | 0.144 0.003 CID_159959 | CID_159959 | |
| 0.122 | 0.028 | 0.122 | Toll-Like receptor 3 antagonist | |||
| 0.208 | 0.113 | 0.245 | Spasmolytic | 0.245 0.094 CID_159959 | CID_159959 | |
| 0.116 | 0.022 | 0.116 | 5 Hydroxytryptamine uptake inhibitor | 0.085 0.032 CID_159959 | ||
| 0.119 | 0.026 | 0.13 | Phosphodiesterase 6D inhibitor | 0.13 0.018 CID_159959 | CID_159959 | |
| 0.136 | 0.044 | 0.153 | MAP kinase 13 inhibitor | 0.153 0.034 CID_159959 | CID_159959 | |
| 0.117 | 0.025 | 0.117 | 5 Hydroxytryptamine 1F antagonist | 0.098 0.032 CID_159959 | ||
| 0.104 | 0.012 | 0.148 | Protein kinase C beta inhibitor | 0.148 0.004 CID_159959 | CID_159959 | |
| 0.113 | 0.021 | 0.113 | Granulocyte macrophage colony stimulating factor agonist | 0.091 0.05 CID_159959 | ||
| 0.113 | 0.022 | 0.14 | Glycine receptor antagonist | 0.14 0.01 CID_159959 | CID_159959 | |
| 0.136 | 0.046 | 0.136 | Aurora-A kinase inhibitor | 0.108 0.06 CID_159959 | ||
| 0.13 | 0.041 | 0.136 | Sphingosine 1-phosphate receptor 2 agonist | 0.136 0.036 CID_159959 | CID_159959 | |
| 0.127 | 0.04 | 0.213 | Carbonic anhydrase III inhibitor | 0.213 0.014 CID_159959 | CID_159959 | |
| 0.091 | 0.004 | 0.091 | 5 Hydroxytryptamine 2B agonist | 0.061 0.008 CID_159959 | ||
| 0.107 | 0.023 | 0.107 | Dopamine D3 antagonist | 0.078 0.033 CID_159959 | ||
| 0.088 | 0.005 | 0.088 | 5 Hydroxytryptamine 1D agonist | 0.069 0.006 CID_159959 | ||
| 0.274 | 0.192 | 0.307 | Apoptosis agonist | 0.307 0.167 CID_159959 | CID_159959 | |
| 0.13 | 0.048 | 0.13 | Polo-like kinase-4 inhibitor | 0.115 0.061 CID_159959 | ||
| 0.09 | 0.011 | 0.09 | Cyclin D1 inhibitor | 0.072 0.026 CID_159959 | ||
| 0.139 | 0.061 | 0.18 | Toll-Like receptor 2 antagonist | 0.18 0.034 CID_159959 | CID_159959 | |
| 0.223 | 0.145 | 0.223 | Angiogenesis inhibitor | |||
| 0.09 | 0.013 | 0.09 | Toll-Like receptor 8 antagonist | 0.07 0.023 CID_159959 | ||
| 0.087 | 0.01 | 0.087 | 5 Hydroxytryptamine 1B agonist | 0.083 0.011 CID_159959 | ||
| 0.087 | 0.01 | 0.089 | Myc inhibitor | 0.089 0.01 CID_159959 | CID_159959 | |
| 0.093 | 0.017 | 0.122 | Beta 3 adrenoreceptor antagonist | 0.122 0.009 CID_159959 | CID_159959 | |
| 0.113 | 0.037 | 0.113 | Phosphodiesterase IV inhibitor | |||
| 0.128 | 0.053 | 0.147 | DNA intercalator | 0.147 0.044 CID_159959 | CID_159959 | |
| 0.131 | 0.056 | 0.131 | Aurora-B kinase inhibitor | 0.097 0.086 CID_159959 | ||
| 0.157 | 0.082 | 0.163 | Cyclin-dependent kinase 3 inhibitor | 0.163 0.07 CID_159959 | CID_159959 | |
| 0.094 | 0.02 | 0.094 | Bombesin 1 receptor agonist | 0.089 0.021 CID_159959 | ||
| 0.125 | 0.051 | 0.137 | Photosensitizer | 0.137 0.04 CID_159959 | CID_159959 | |
| 0.212 | 0.138 | 0.224 | Hypoxia-inducible factor 1 alpha inhibitor | 0.224 0.125 CID_159959 | CID_159959 | |
| 0.096 | 0.023 | 0.096 | Phosphodiesterase VI inhibitor | 0.081 0.04 CID_159959 | ||
| 0.12 | 0.049 | 0.12 | MAP kinase 9 inhibitor | 0.12 0.05 CID_159959 | ||
| 0.141 | 0.074 | 0.141 | Vascular endothelial growth factor 3 antagonist | |||
| 0.086 | 0.021 | 0.086 | Aryl hydrocarbon receptor antagonist | 0.078 0.028 CID_159959 | ||
| 0.091 | 0.026 | 0.116 | Protein kinase C alpha inhibitor | 0.116 0.017 CID_159959 | CID_159959 | |
| 0.085 | 0.022 | 0.127 | Protein kinase C eta inhibitor | 0.127 0.011 CID_159959 | CID_159959 | |
| 0.09 | 0.026 | 0.09 | Acetylcholine M5 receptor agonist | |||
| 0.232 | 0.169 | 0.348 | Histamine release inhibitor | 0.348 0.101 CID_159959 | CID_159959 | |
| 0.097 | 0.034 | 0.097 | Nicotinic alpha4beta2 receptor antagonist | 0.088 0.042 CID_159959 | ||
| 0.082 | 0.02 | 0.097 | Cyclin B1 inhibitor | 0.097 0.012 CID_159959 | CID_159959 | |
| 0.089 | 0.027 | 0.108 | GABA B receptor agonist | 0.108 0.012 CID_159959 | CID_159959 | |
| 0.077 | 0.016 | 0.094 | Cyclin B2 inhibitor | 0.094 0.01 CID_159959 | CID_159959 | |
| 0.091 | 0.031 | 0.128 | Dopamine agonist | 0.128 0.019 CID_159959 | CID_159959 | |
| 0.102 | 0.042 | 0.102 | Phosphodiesterase I inhibitor | 0.086 0.065 CID_159959 | ||
| 0.193 | 0.134 | 0.251 | DNA synthesis inhibitor | 0.251 0.066 CID_159959 | CID_159959 | |
| 0.089 | 0.03 | 0.089 | Neuronal nicotinic receptor antagonist | 0.083 0.034 CID_159959 | ||
| 0.092 | 0.035 | 0.092 | Acetylcholine M4 receptor antagonist | 0.068 0.06 CID_159959 | ||
| 0.067 | 0.009 | 0.184 | Dopamine D5 agonist | 0.184 0.002 CID_159959 | CID_159959 | |
| 0.119 | 0.063 | 0.177 | Interleukin 8 antagonist | 0.177 0.02 CID_159959 | CID_159959 | |
| 0.063 | 0.006 | 0.07 | Phenylethanolamine N methyltransferase inhibitor | 0.07 0.005 CID_159959 | CID_159959 | |
| 0.089 | 0.033 | 0.095 | Alpha adrenoreceptor agonist | 0.095 0.03 CID_159959 | CID_159959 | |
| 0.082 | 0.026 | 0.082 | Adrenaline uptake inhibitor | 0.078 0.028 CID_159959 | ||
| 0.097 | 0.042 | 0.097 | Acetylcholine nicotinic antagonist | 0.09 0.046 CID_159959 | ||
| 0.09 | 0.037 | 0.127 | CC chemokine 5 receptor agonist | 0.127 0.006 CID_159959 | CID_159959 | |
| 0.072 | 0.02 | 0.09 | Cyclin B inhibitor | 0.09 0.012 CID_159959 | CID_159959 | |
| 0.075 | 0.022 | 0.075 | Potassium channel (Ca-activated) blocker | |||
| 0.125 | 0.072 | 0.125 | Cyclooxygenase 3 inhibitor | 0.123 0.074 CID_159959 | ||
| 0.061 | 0.009 | 0.061 | Acid-sensing ion channel blocker | 0.061 0.009 CID_159959 | ||
| 0.094 | 0.042 | 0.094 | Inducible nitric-oxide synthase inhibitor | 0.089 0.049 CID_159959 | ||
| 0.095 | 0.043 | 0.106 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.106 0.033 CID_159959 | CID_159959 | |
| 0.103 | 0.052 | 0.152 | HIV-1 integrase (Overall Integration) inhibitor | 0.152 0.025 CID_159959 | CID_159959 | |
| 0.066 | 0.016 | 0.086 | Dopamine D5 antagonist | 0.086 0.011 CID_159959 | CID_159959 | |
| 0.131 | 0.082 | 0.216 | Lipid peroxidase inhibitor | 0.216 0.035 CID_159959 | CID_159959 | |
| 0.15 | 0.102 | 0.173 | Neurotensin receptor agonist | 0.173 0.058 CID_159959 | CID_159959 | |
| 0.15 | 0.102 | 0.15 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.064 | 0.017 | 0.064 | Alpha 1L adrenoreceptor antagonist | |||
| 0.096 | 0.05 | 0.096 | Glutamate release inhibitor | |||
| 0.053 | 0.007 | 0.053 | Melatonin antagonist | |||
| 0.071 | 0.027 | 0.114 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.114 0.007 CID_159959 | CID_159959 | |
| 0.133 | 0.089 | 0.416 | Peroxidase inhibitor | 0.416 0.018 CID_159959 | CID_159959 | |
| 0.05 | 0.008 | 0.05 | Melatonin receptor 1A agonist | |||
| 0.075 | 0.032 | 0.094 | Beta adrenoreceptor antagonist | 0.094 0.019 CID_159959 | CID_159959 | |
| 0.067 | 0.029 | 0.078 | Beta 1 adrenoreceptor antagonist | 0.078 0.019 CID_159959 | CID_159959 | |
| 0.088 | 0.05 | 0.088 | ALK inhibitor | |||
| 0.137 | 0.099 | 0.162 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.162 0.082 CID_159959 | CID_159959 | |
| 0.068 | 0.034 | 0.083 | Alpha 2 adrenoreceptor agonist | 0.083 0.022 CID_159959 | CID_159959 | |
| 0.068 | 0.034 | 0.068 | Protein kinase C iota inhibitor | 0.064 0.037 CID_159959 | ||
| 0.063 | 0.029 | 0.063 | Phosphodiesterase II inhibitor | |||
| 0.047 | 0.014 | 0.055 | Somatostatin 5 agonist | 0.055 0.011 CID_159959 | CID_159959 | |
| 0.088 | 0.056 | 0.27 | NMDA receptor antagonist | 0.27 0.008 CID_159959 | CID_159959 | |
| 0.086 | 0.053 | 0.108 | D-Ala-D-Ala ligase inhibitor | 0.108 0.021 CID_159959 | CID_159959 | |
| 0.064 | 0.032 | 0.064 | Alpha 1 adrenoreceptor agonist | 0.053 0.046 CID_159959 | ||
| 0.123 | 0.091 | 0.123 | Nav1.6 sodium channel blocker | |||
| 0.168 | 0.137 | 0.168 | ErbB-1 antagonist | |||
| 0.136 | 0.105 | 0.168 | Arachidonic acid antagonist | 0.168 0.067 CID_159959 | CID_159959 | |
| 0.083 | 0.053 | 0.14 | Carbonic anhydrase VI inhibitor | 0.14 0.023 CID_159959 | CID_159959 | |
| 0.145 | 0.116 | 0.206 | Phospholipase C inhibitor | 0.206 0.04 CID_159959 | CID_159959 | |
| 0.049 | 0.02 | 0.062 | GABA B receptor antagonist | 0.062 0.011 CID_159959 | CID_159959 | |
| 0.095 | 0.068 | 0.095 | Nitric-oxide synthase inhibitor | 0.092 0.074 CID_159959 | ||
| 0.129 | 0.102 | 0.151 | Anticoagulant | 0.151 0.08 CID_159959 | CID_159959 | |
| 0.051 | 0.024 | 0.051 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.048 | 0.022 | 0.048 | Glutamate (mGluR1a) antagonist | 0.037 0.033 CID_159959 | ||
| 0.149 | 0.124 | 0.176 | Death-associated protein kinase 3 inhibitor | 0.176 0.091 CID_159959 | CID_159959 | |
| 0.057 | 0.032 | 0.057 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.105 | 0.081 | 0.105 | Microtubule formation inhibitor | 0.101 0.09 CID_159959 | ||
| 0.033 | 0.009 | 0.051 | Somatostatin 3 antagonist | 0.051 0.007 CID_159959 | CID_159959 | |
| 0.035 | 0.011 | 0.035 | 5 Hydroxytryptamine 6 agonist | 0.033 0.013 CID_159959 | ||
| 0.067 | 0.044 | 0.077 | Cyclin-dependent kinase 4 inhibitor | 0.077 0.036 CID_159959 | CID_159959 | |
| 0.086 | 0.063 | 0.086 | Bromodomain-containing protein 2 inhibitor | |||
| 0.068 | 0.046 | 0.068 | Phosphodiesterase 4B inhibitor | |||
| 0.061 | 0.04 | 0.061 | Phosphodiesterase 1A inhibitor | 0.055 0.054 CID_159959 | ||
| 0.038 | 0.017 | 0.038 | Melatonin 1 agonist | |||
| 0.034 | 0.013 | 0.034 | Nicotinic alpha4beta2 receptor agonist | 0.03 0.017 CID_159959 | ||
| 0.07 | 0.05 | 0.07 | Benzodiazepine agonist | |||
| 0.035 | 0.015 | 0.035 | Nicotinic alpha3beta4 receptor agonist | 0.035 0.014 CID_159959 | ||
| 0.037 | 0.017 | 0.037 | Melatonin agonist | |||
| 0.048 | 0.028 | 0.049 | Phosphodiesterase 6C inhibitor | 0.049 0.024 CID_159959 | CID_159959 | |
| 0.052 | 0.033 | 0.074 | Beta 2 adrenoreceptor antagonist | 0.074 0.014 CID_159959 | CID_159959 | |
| 0.051 | 0.033 | 0.051 | Phosphodiesterase 2A inhibitor | |||
| 0.041 | 0.023 | 0.041 | TRPM8 blocker | |||
| 0.096 | 0.078 | 0.134 | Cyclin-dependent kinase 5 inhibitor | 0.134 0.05 CID_159959 | CID_159959 | |
| 0.089 | 0.072 | 0.089 | Alpha 2d adrenoreceptor antagonist | |||
| 0.151 | 0.134 | 0.195 | Dyrk kinase inhibitor | 0.195 0.101 CID_159959 | CID_159959 | |
| 0.148 | 0.132 | 0.195 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.195 0.096 CID_159959 | CID_159959 | |
| 0.103 | 0.087 | 0.125 | Cyclin-dependent kinase inhibitor | 0.125 0.071 CID_159959 | CID_159959 | |
| 0.02 | 0.004 | 0.02 | Melatonin 2 antagonist | |||
| 0.059 | 0.043 | 0.059 | Dopamine D4 antagonist | |||
| 0.02 | 0.005 | 0.02 | Melatonin receptor 1A antagonist | |||
| 0.077 | 0.063 | 0.098 | Protein kinase A inhibitor | 0.098 0.047 CID_159959 | CID_159959 | |
| 0.062 | 0.049 | 0.062 | Calcium channel P-type blocker | |||
| 0.023 | 0.009 | 0.023 | Melatonin 1 antagonist | |||
| 0.025 | 0.012 | 0.043 | Dopamine D1 agonist | 0.043 0.005 CID_159959 | CID_159959 | |
| 0.065 | 0.052 | 0.065 | Glutamate (mGluR7) antagonist | |||
| 0.072 | 0.059 | 0.109 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.109 0.033 CID_159959 | CID_159959 | |
| 0.048 | 0.036 | 0.048 | Nicotinic receptor alpha4 subunit antagonist | 0.048 0.038 CID_159959 | ||
| 0.048 | 0.036 | 0.055 | Bombesin 2 receptor antagonist | 0.055 0.028 CID_159959 | CID_159959 | |
| 0.033 | 0.022 | 0.033 | Melatonin 2 agonist | |||
| 0.06 | 0.049 | 0.08 | 5 Hydroxytryptamine 3 agonist | 0.08 0.027 CID_159959 | CID_159959 | |
| 0.074 | 0.064 | 0.074 | Histamine H1 receptor antagonist | |||
| 0.085 | 0.074 | 0.111 | Pim-1 kinase inhibitor | 0.111 0.048 CID_159959 | CID_159959 | |
| 0.063 | 0.053 | 0.081 | CDC7 inhibitor | 0.081 0.034 CID_159959 | CID_159959 | |
| 0.035 | 0.026 | 0.063 | Kainate receptor 2 antagonist | 0.063 0.011 CID_159959 | CID_159959 | |
| 0.033 | 0.024 | 0.04 | Protein kinase C beta I inhibitor | 0.04 0.009 CID_159959 | CID_159959 | |
| 0.042 | 0.033 | 0.166 | NMDA receptor subunit 3B antagonist | 0.166 0.005 CID_159959 | CID_159959 | |
| 0.042 | 0.033 | 0.043 | Nicotinic receptor alpha3 subunit antagonist | 0.043 0.032 CID_159959 | CID_159959 | |
| 0.112 | 0.104 | 0.112 | CDC-like kinase 1 inhibitor | |||
| 0.035 | 0.028 | 0.087 | Kinesin-like protein 1 inhibitor | 0.087 0.009 CID_159959 | CID_159959 | |
| 0.035 | 0.028 | 0.087 | Kinesin antagonist | 0.087 0.009 CID_159959 | CID_159959 | |
| 0.045 | 0.038 | 0.045 | Benzodiazepine antagonist | |||
| 0.069 | 0.061 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.098 0.034 CID_159959 | CID_159959 | |
| 0.051 | 0.044 | 0.059 | Pim-2 kinase inhibitor | 0.059 0.032 CID_159959 | CID_159959 | |
| 0.093 | 0.086 | 0.093 | GABA receptor agonist | |||
| 0.16 | 0.153 | 0.276 | Antioxidant | 0.276 0.071 CID_159959 | CID_159959 | |
| 0.048 | 0.042 | 0.048 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.031 | 0.025 | 0.031 | GHS receptor antagonist | |||
| 0.043 | 0.038 | 0.066 | Purinergic P2X4 antagonist | 0.066 0.011 CID_159959 | CID_159959 | |
| 0.08 | 0.076 | 0.089 | Pim-3 kinase inhibitor | 0.089 0.06 CID_159959 | CID_159959 | |
| 0.11 | 0.106 | 0.124 | Protein kinase C nu inhibitor | 0.124 0.089 CID_159959 | CID_159959 | |
| 0.076 | 0.072 | 0.076 | GABA A receptor agonist | |||
| 0.048 | 0.044 | 0.048 | Alpha tubulin antagonist | |||
| 0.058 | 0.054 | 0.058 | Phosphodiesterase III inhibitor | |||
| 0.031 | 0.028 | 0.041 | Protein kinase C beta II inhibitor | 0.041 0.01 CID_159959 | CID_159959 | |
| 0.117 | 0.114 | 0.151 | Acetylcholine M1 receptor antagonist | 0.151 0.073 CID_159959 | CID_159959 | |
| 0.015 | 0.013 | 0.015 | Nicotinic alpha4 receptor agonist | |||
| 0.04 | 0.038 | 0.04 | Alpha 1L adrenoreceptor agonist | |||
| 0.094 | 0.092 | 0.155 | Topoisomerase II inhibitor | 0.155 0.047 CID_159959 | CID_159959 | |
| 0.049 | 0.047 | 0.049 | Beta tubulin antagonist | |||
| 0.054 | 0.052 | 0.054 | Phosphodiesterase 1B inhibitor | |||
| 0.043 | 0.041 | 0.043 | Phosphodiesterase 4A inhibitor | |||
| 0.107 | 0.106 | 0.107 | DNA repair enzyme inhibitor | |||
| 0.204 | 0.203 | 0.235 | Antiobesity | 0.235 0.172 CID_159959 | CID_159959 | |
| 0.078 | 0.079 | 0.113 | Protein kinase C delta inhibitor | 0.113 0.042 CID_159959 | CID_159959 | |
| 0.134 | 0.136 | 0.169 | MAP kinase kinase 2 inhibitor | 0.169 0.105 CID_159959 | CID_159959 | |
| 0.02 | 0.022 | 0.043 | Kainate receptor 4 antagonist | 0.043 0.008 CID_159959 | CID_159959 | |
| 0.128 | 0.131 | 0.143 | Ca2+-transporting ATPase inhibitor | 0.143 0.062 CID_159959 | CID_159959 | |
| 0.107 | 0.11 | 0.133 | Protein kinase stimulant | 0.133 0.081 CID_159959 | CID_159959 | |
| 0.131 | 0.135 | 0.169 | Pyruvate kinase inhibitor | 0.169 0.101 CID_159959 | CID_159959 | |
| 0.051 | 0.055 | 0.09 | Androgen agonist | 0.09 0.019 CID_159959 | CID_159959 | |
| 0.123 | 0.129 | 0.142 | Melanin inhibitor | 0.142 0.094 CID_159959 | CID_159959 | |
| 0.046 | 0.054 | 0.055 | CDK4/cyclin D1 inhibitor | 0.055 0.043 CID_159959 | CID_159959 | |
| 0.134 | 0.146 | 0.155 | Succinate dehydrogenase inhibitor | 0.155 0.103 CID_159959 | CID_159959 | |
| 0.07 | 0.085 | 0.083 | Myeloperoxidase inhibitor | 0.083 0.061 CID_159959 | CID_159959 | |
| 0.04 | 0.056 | 0.049 | Protein kinase C epsilon inhibitor | 0.049 0.042 CID_159959 | CID_159959 | |
| 0.04 | 0.058 | 0.064 | Topoisomerase II beta inhibitor | 0.064 0.019 CID_159959 | CID_159959 | |
| 0.06 | 0.079 | 0.072 | Glycine receptor agonist | 0.072 0.051 CID_159959 | CID_159959 | |
| 0.03 | 0.049 | 0.05 | CDK5/p25 inhibitor | 0.05 0.021 CID_159959 | CID_159959 | |
| 0.011 | 0.031 | 0.017 | Kainate receptor 3 antagonist | 0.017 0.012 CID_159959 | CID_159959 | |
| 0.047 | 0.067 | 0.095 | NMDA 2C receptor antagonist | 0.095 0.017 CID_159959 | CID_159959 | |
| 0.026 | 0.046 | 0.049 | Estrogen-related receptor beta antagonist | 0.049 0.005 CID_159959 | CID_159959 | |
| 0.048 | 0.069 | 0.073 | Heat shock protein 90 beta antagonist | 0.073 0.026 CID_159959 | CID_159959 | |
| 0.064 | 0.085 | 0.102 | Estrogen receptor alpha antagonist | 0.102 0.026 CID_159959 | CID_159959 | |
| 0.012 | 0.034 | 0.024 | Kainate receptor 5 antagonist | 0.024 0.013 CID_159959 | CID_159959 | |
| 0.064 | 0.087 | 0.113 | Androgen antagonist | 0.113 0.037 CID_159959 | CID_159959 | |
| 0.147 | 0.17 | 0.202 | Interleukin agonist | 0.202 0.119 CID_159959 | CID_159959 | |
| 0.109 | 0.134 | 0.124 | Aurora-C kinase inhibitor | 0.124 0.097 CID_159959 | CID_159959 | |
| 0.091 | 0.116 | 0.11 | Glycogen synthase kinase-3 alpha inhibitor | 0.11 0.093 CID_159959 | CID_159959 | |
| 0.117 | 0.142 | 0.129 | Pregnane X receptor agonist | 0.129 0.103 CID_159959 | CID_159959 | |
| 0.082 | 0.107 | 0.111 | Beta glucuronidase inhibitor | 0.111 0.055 CID_159959 | CID_159959 | |
| 0.042 | 0.068 | 0.075 | CXC chemokine 4 receptor antagonist | 0.075 0.034 CID_159959 | CID_159959 | |
| 0.057 | 0.085 | 0.076 | Phospholipase D inhibitor | 0.076 0.041 CID_159959 | CID_159959 | |
| 0.023 | 0.051 | 0.104 | NMDA receptor subunit 3A antagonist | 0.104 0.008 CID_159959 | CID_159959 | |
| 0.04 | 0.07 | 0.05 | Lysine-specific demethylase 1A inhibitor | 0.05 0.045 CID_159959 | CID_159959 | |
| 0.084 | 0.115 | 0.143 | Amylase inhibitor | 0.143 0.068 CID_159959 | CID_159959 | |
| 0.122 | 0.156 | 0.143 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.143 0.118 CID_159959 | CID_159959 | |
| 0.053 | 0.087 | 0.093 | Topoisomerase II alpha inhibitor | 0.093 0.044 CID_159959 | CID_159959 | |
| 0.023 | 0.059 | 0.04 | Opioid delta receptor agonist | 0.04 0.02 CID_159959 | CID_159959 | |
| 0.067 | 0.102 | 0.094 | Cyclin-dependent kinase 1 inhibitor | 0.094 0.07 CID_159959 | CID_159959 | |
| 0.024 | 0.061 | 0.049 | Dopamine D2 agonist | 0.049 0.028 CID_159959 | CID_159959 | |
| 0.059 | 0.099 | 0.099 | Histamine N-methyltransferase inhibitor | 0.099 0.047 CID_159959 | CID_159959 | |
| 0.116 | 0.157 | 0.132 | CF transmembrane conductance regulator agonist | 0.132 0.112 CID_159959 | CID_159959 | |
| 0.082 | 0.124 | 0.138 | DOPA decarboxylase inhibitor | 0.138 0.028 CID_159959 | CID_159959 | |
| 0.02 | 0.063 | 0.03 | Estrogen-related receptor gamma antagonist | 0.03 0.015 CID_159959 | CID_159959 | |
| 0.065 | 0.109 | 0.091 | Potassium channel activator | 0.091 0.058 CID_159959 | CID_159959 | |
| 0.027 | 0.071 | 0.069 | AMPA 4 receptor antagonist | 0.069 0.008 CID_159959 | CID_159959 | |
| 0.02 | 0.065 | 0.05 | Kainate receptor antagonist | 0.05 0.021 CID_159959 | CID_159959 | |
| 0.053 | 0.099 | 0.062 | Prolactin release inhibitor | 0.062 0.043 CID_159959 | CID_159959 | |
| 0.069 | 0.116 | 0.086 | Estrogen-related receptor beta agonist | 0.086 0.051 CID_159959 | CID_159959 | |
| 0.005 | 0.053 | 0.022 | Kainate receptor 1 antagonist | 0.022 0.014 CID_159959 | CID_159959 | |
| 0.171 | 0.219 | 0.214 | Antithrombotic | 0.214 0.161 CID_159959 | CID_159959 | |
| 0.012 | 0.061 | 0.048 | AMPA 3 receptor antagonist | 0.048 0.01 CID_159959 | CID_159959 | |
| 0.137 | 0.188 | 0.157 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.157 0.133 CID_159959 | CID_159959 | |
| 0.066 | 0.117 | 0.089 | NADH dehydrogenase inhibitor | 0.089 0.058 CID_159959 | CID_159959 | |
| 0.071 | 0.123 | 0.091 | Bile acid receptor antagonist | 0.091 0.07 CID_159959 | CID_159959 | |
| 0.032 | 0.084 | 0.117 | Opioid delta receptor antagonist | 0.117 0.027 CID_159959 | CID_159959 | |
| 0.107 | 0.161 | 0.134 | Nitric oxide antagonist | 0.134 0.113 CID_159959 | CID_159959 | |
| 0.089 | 0.143 | 0.14 | Histone deacetylase SIRT1 inhibitor | 0.14 0.071 CID_159959 | CID_159959 | |
| 0.054 | 0.108 | 0.105 | Adrenaline agonist | 0.105 0.034 CID_159959 | CID_159959 | |
| 0.084 | 0.139 | 0.17 | Estrogen antagonist | 0.17 0.018 CID_159959 | CID_159959 | |
| 0.056 | 0.112 | 0.103 | Opioid kappa receptor antagonist | 0.103 0.032 CID_159959 | CID_159959 | |
| 0.055 | 0.111 | 0.074 | Keratolytic | 0.074 0.058 CID_159959 | CID_159959 | |
| 0.108 | 0.165 | 0.127 | Sphingosine 1-phosphate receptor 5 antagonist | 0.127 0.108 CID_159959 | CID_159959 | |
| 0.011 | 0.069 | 0.033 | AMPA 2 receptor antagonist | 0.033 0.018 CID_159959 | CID_159959 | |
| 0.072 | 0.131 | 0.099 | AMP-activated protein kinase stimulant | 0.099 0.071 CID_159959 | CID_159959 | |
| 0.108 | 0.169 | 0.13 | Interferon gamma antagonist | 0.13 0.11 CID_159959 | CID_159959 | |
| 0.067 | 0.131 | 0.107 | Anabolic | 0.107 0.053 CID_159959 | CID_159959 | |
| 0.161 | 0.227 | 0.232 | Insulysin inhibitor | 0.232 0.115 CID_159959 | CID_159959 | |
| 0.04 | 0.106 | 0.088 | Histidine decarboxylase inhibitor | 0.088 0.037 CID_159959 | CID_159959 | |
| 0.067 | 0.133 | 0.114 | Cystathionine beta-synthase inhibitor | 0.114 0.063 CID_159959 | CID_159959 | |
| 0.105 | 0.173 | 0.135 | Anesthetic general | 0.135 0.131 CID_159959 | CID_159959 | |
| 0.042 | 0.111 | 0.063 | Sirtuin 1 inhibitor | 0.063 0.053 CID_159959 | CID_159959 | |
| 0.045 | 0.114 | 0.093 | Analgesic, opioid | 0.093 0.035 CID_159959 | CID_159959 | |
| 0.097 | 0.167 | 0.123 | Cyclin-dependent kinase 8 inhibitor | 0.123 0.113 CID_159959 | CID_159959 | |
| 0.107 | 0.179 | 0.135 | Hepatoprotectant | 0.135 0.127 CID_159959 | CID_159959 | |
| 0.005 | 0.08 | 0.044 | AMPA 1 receptor antagonist | 0.044 0.013 CID_159959 | CID_159959 | |
| 0.02 | 0.097 | 0.049 | AMPA receptor antagonist | 0.049 0.032 CID_159959 | CID_159959 | |
| 0.052 | 0.132 | 0.115 | Opioid antagonist | 0.115 0.039 CID_159959 | CID_159959 | |
| 0.064 | 0.146 | 0.127 | Adenylate cyclase inhibitor | 0.127 0.062 CID_159959 | CID_159959 | |
| 0.039 | 0.123 | 0.06 | I kappa B kinase 2 inhibitor | 0.06 0.047 CID_159959 | CID_159959 | |
| 0.139 | 0.228 | 0.181 | RNA-directed DNA polymerase inhibitor | 0.181 0.131 CID_159959 | CID_159959 | |
| 0.029 | 0.118 | 0.095 | Opioid mu receptor antagonist | 0.095 0.033 CID_159959 | CID_159959 | |
| 0.061 | 0.151 | 0.144 | Estrogen receptor beta antagonist | 0.144 0.017 CID_159959 | CID_159959 | |
| 0.147 | 0.237 | 0.18 | Neuropeptide Y2 antagonist | 0.18 0.16 CID_159959 | CID_159959 | |
| 0.069 | 0.168 | 0.137 | Alpha-N-acetylglucosaminidase inhibitor | 0.137 0.063 CID_159959 | CID_159959 | |
| 0.042 | 0.147 | 0.086 | Somatostatin 1 agonist | 0.086 0.045 CID_159959 | CID_159959 | |
| 0.068 | 0.173 | 0.094 | Adenylate kinase inhibitor | 0.094 0.079 CID_159959 | CID_159959 | |
| 0.079 | 0.187 | 0.163 | Angiogenesis stimulant | 0.163 0.115 CID_159959 | CID_159959 | |
| 0.035 | 0.144 | 0.092 | Glutamate decarboxylase inhibitor | 0.092 0.035 CID_159959 | CID_159959 | |
| 0.016 | 0.129 | 0.043 | Opioid mu receptor agonist | 0.043 0.037 CID_159959 | CID_159959 | |
| 0.049 | 0.17 | 0.164 | Creatine kinase inhibitor | 0.164 0.019 CID_159959 | CID_159959 | |
| 0.021 | 0.145 | 0.061 | Alcohol oxidase inhibitor | 0.061 0.035 CID_159959 | CID_159959 | |
| 0.014 | 0.138 | 0.052 | NMDA 2A receptor antagonist | 0.052 0.036 CID_159959 | CID_159959 | |
| 0.005 | 0.136 | 0.058 | Estrogen receptor beta agonist | 0.058 0.018 CID_159959 | CID_159959 | |
| 0.05 | 0.182 | 0.09 | Ferrochelatase inhibitor | 0.09 0.083 CID_159959 | CID_159959 | |
| 0.042 | 0.178 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.056 CID_159959 | CID_159959 | |
| 0.076 | 0.212 | 0.107 | Transcription factor STAT6 inhibitor | 0.107 0.088 CID_159959 | CID_159959 | |
| 0.027 | 0.168 | 0.103 | Phenylalanine 4-hydroxylase inhibitor | 0.103 0.024 CID_159959 | CID_159959 | |
| 0.028 | 0.169 | 0.098 | Porphobilinogen synthase inhibitor | 0.098 0.037 CID_159959 | CID_159959 | |
| 0.048 | 0.191 | 0.091 | UDP-glucose 4-epimerase inhibitor | 0.091 0.071 CID_159959 | CID_159959 | |
| 0.024 | 0.168 | 0.049 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.049 0.044 CID_159959 | CID_159959 | |
| 0.009 | 0.164 | 0.056 | Estrogen agonist | 0.056 0.032 CID_159959 | CID_159959 | |
| 0.004 | 0.16 | 0.037 | Estrogen receptor alpha agonist | 0.037 0.022 CID_159959 | CID_159959 | |
| 0.014 | 0.19 | 0.07 | NMDA 2 receptor antagonist | 0.07 0.051 CID_159959 | CID_159959 | |
| 0.039 | 0.238 | 0.103 | Glutamate receptor antagonist | 0.103 0.093 CID_159959 | CID_159959 | |
| 0.11 | 0.36 | 0.216 | Sodium/bile acid cotransporter inhibitor | 0.216 0.166 CID_159959 | CID_159959 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |